The leaves and root bark of Morus alba, the white mulberry tree, are well-known traditional medicines for the treatment of type II diabetes. Several different types of constituents have been suggested to be responsible for the anti-diabetic activity of mulberry drugs, such as iminosugars, flavonoids and other phenolic compounds, glycopeptides and ecdysteroids. Our group recently suggested that a volatile-oil like fraction of the hot water extract of M. alba leaves, containing several phenyl-propane derivatives, can increase the glucose consumption of adipocytes. Here we report the isolation of three glycosylated volatile constituents from mulberry leaves, two megastigmane derivatives along with the β-D-glucoside of eugenol. Furthermore, a commercially available mixture of probiotic bacteria was assessed to study the effect of the intestinal flora on the megastigmane derivatives. Significant amounts of the aglycons of both compounds were liberated, suggesting that these compounds can be metabolized in the large intestines and absorbed without the sugar moiety after the consumption of a traditional mulberry tea. Based on literature data, both the glycosides and their aglycons have a potential contribution to the beneficial effects of mulberry leaves in type 2 diabetes.
According to the most recent WHO data, around 350 million people worldwide have diabetes, which is projected to become the 7 th leading cause of death in 2030. Type II diabetes, or rather noninsulin dependent diabetes mellitus (NIDDM), which is closely connected to overweight and physical inactivity, accounts for 90% of the cases [1] . Therapy of this malignant and progressive disease involves a lifestyle change and the use of oral anti-diabetics [2] . Considering the complex pathology of NIDDM, rational phytotherapy, due to its "multi-target" approach, can provide a valuable complement or alternative to the classical therapeutic strategies.
The leaves and root bark of Morus alba L., the white mulberry tree, are worldwide used for the treatment of diabetes: in fact, this use seems to be the only one recognized by local traditional medicine wherever this tree has been naturalized [3] . A significant body of literature on the anti-diabetic activity of various mulberry preparations has been published, including several in vivo animal and clinical studies [4] . This anti-diabetic activity appears to arise from a complex cocktail of many different kinds of constituents, among which certain phenolic compounds [4] and sugar-mimic polyhydroxy-piperidine alkaloids (iminosugars) [5] play probably the most important role. Nevertheless, mulberry drugs are rich in several other compounds that probably contribute to the beneficial activity in diabetes, such as glycopeptides [6], polysaccharides [7] , and ecdysteroids [8] . Recently, we have reported the activity and chemical characterization of a volatile oil-like fraction obtained from the hot water extract of mulberry leaves that significantly increased the glucose consumption of adipocytes [9] . Based on this, volatile compounds, such as apolar, less oxidized terpenes and phenylpropanes of mulberry also have the potential to contribute to the complex anti-diabetic activity. As a direct continuation of our previous work, here we report the isolation of three glycosylated volatile constituents of M. alba, all of which, based on literature data, might contribute to such activity. By a combination of various For the latter two compounds, a 6R,9R configuration is suggested based on literature data [11] . chromatographic techniques of different selectivity, three compounds were isolated from the frozen fresh extract of M. alba.
Structures of compounds 1-3 were determined by means of their 1D and 2D NMR spectra. Spectral data of compound 1 (0.75 mg, 0.0031% yield) were in good agreement with those published for eugenol O-β-D-glucopyranoside, a common phenylpropane glycoside [10] . In the case of compound 2, the glycosidic structure was suggested by the 1 H and 13 C spectra. In the 1 H spectrum, four methyl groups were identified. The 13 C signal of a conjugated C=O at δ 202.3, together with the strong UV absorbance at 245 nm, suggested the presence of an α,β-enone moiety, which was also supported by the olefinic singlet in the 1 H spectrum at δ 5.88. From the 1 H-1 H COSY spectrum, two neighboring olefin hydrogens (δ 5.78 and 5.65) were also identified, and their coupling constant of 15.4 Hz revealed the E configuration of this double bond. The 1 H-1 H COSY correlations starting from δ 4.36, in addition to the 3 J (H,H) values revealed the presence of a β-D-glucopyranoside unit. The 1 H and 13 C signal assignment was achieved by utilizing HMQC, HMBC and NOESY spectra. The structure of compound 3 was found to be a side-chain saturated derivative of 2. Based on the spectral data, the relative configuration of C-6 and C-9 could not be determined for compounds 2 and 3, however literature data on the aglycons strongly suggested a 6R,9R structure for both [11] (see below). Structures of glycosides 2 and 3 were also confirmed by means of literature data [12] . Structures of compounds 1-3, as well as numbering and characteristic HMBC and NOESY correlations of 2 and 3, are shown in Figure 1 .
A similar megastigmane derivative has previously been isolated from Pterospermum semisagittatum, differing from compound 2 only in a 6α-OH substituent. This compound was found to exert significant insulin liberating activity at 1µM on rat pancreatic islets in vitro [13] , and was suggested to play a significant role in the antihyperglycemic activity of P. semisagittatum. Based on the structural analogy, compounds 2 and 3 might have similar activity. Moreover, to our best knowledge, our results represent the first report of megastigmane glycosides from Morus sp., and there has been only one previous report of a related compound from the Moraceae family, from Ficus religiosa.
Most interestingly, however, the aglycons of both 2 and 3 have recently been reported from silkworm feces [11] . Based on the fact, that neither of those compounds could be identified in the mulberry leaves, they were suggested to be results of a biotransformation process within the intestine of the worm. Based on our results, we can conclude that most likely a glycosidic cleavage led to the formation of the reported compounds.
In order to investigate the possible role of the human intestinal flora in the metabolism of 2 and 3, we attempted to perform bacterial fermentation on these compounds by using a commercially available mixture of probiotic bacteria, followed by testing the mixture for the presence of aglycons. Due to the small amounts available, a semi-quantitative approach was chosen for checking the conversion by TLC-densitometry, and significant amounts, approximately 60-70% of both compounds, were found to have lost the sugar moiety after 72 hours of fermentation. Identity of these compounds as the aglycons of 2 and 3 (compounds 2' and 3', respectively) was confirmed by GC-MS.
Although 72 hours is a very long time compared with a normal GI passage, it can be stated that bacteria normally present in the intestinal flora are indeed able to metabolize these compounds, allowing them, at least partially, to be absorbed as aglycons.
Our results have several interesting aspects in view of the bioactivity of mulberry leaves in NIDDM. The fraction of 2 and 3 being absorbed unchanged can possibly exert an insulin-liberating effect on the pancreatic β-cells, similarly to the analog reported by Khan et al. [13] . On the other hand, compound 3' and another, similar aglycon (both isolated from silkworm feces), were found to increase significantly the expression of heme oxygenase-1 (an antioxidant enzyme) and SIRT1 (involved in the suppression of several inflammatory mediators) [11] . Considering that both oxidative stress and inflammation are well-known for their role in the progression of type 2 diabetes, the aglycons being absorbed might have a protecting effect on the β-cells. Moreover, the phenylpropane glycoside 1 suggests the presence of further volatile glycosides in mulberry leaves, whose liberated aglycons will certainly add-up to the previously observed effect of the volatile oillike fraction on the glucose consumption of adipocytes [9] . Furthermore, although our results are rather preliminary in this regard, using a mixture of probiotic bacteria seems to be a reasonable approach for studying the rate of glycosidic cleavage, a crucial part of the intestinal metabolism of many natural products. Development of this model is currently in process.
Experimental
General experimental procedures: NMR spectra were recorded in CD 3 OD in Shigemi sample tubes at room temperature with a Bruker Avance DRX-500 spectrometer. The structures of products were determined by comprehensive one-and two-dimensional NMR methods, using widely accepted strategies [15] . Chemical shifts are given on the δ-scale and were referenced to the solvent (CD 3 OD: δC = 49.15 and δH = 3.31). In the 1D measurement ( 1 H, 13 C APT), 64 K data points were used for the FID. The pulse programs of all experiments [gs-COSY, gs-HMQC; gs-HMBC, NOESY (mixing time = 350 ms), 1D gs-TOCSY (mixing time = 40-100 ms) and 1D gs-NOESY (mixing time = 400 ms)] were taken from the Bruker software library. GC-MS was performed on a Finnigan GCQ ion trap bench-top mass spectrometer, by using a DB-5MS 30 m x 0.25 mm x 0.25 μm capillary column. Temperature program was 60°C -210°C at 3°C min -1 , and 210°C -250°C (2 min hold) at 5°C min -1 . Detector and injector temperature was 250°C. Helium was used as carrier gas at a linear velocity of 31.9 cm sec -1 , and split sample introduction was applied. EI-MS was used in positive ion mode, and mass range was 40-400 amu.
Extraction and isolation:
Fresh, frozen leaves of M. alba were extracted in 3 consecutive steps, by sonication with altogether 3.3 L of 50% aqueous MeOH. The evaporated dry residue (24 g) was redissolved in 150 mL of 50% aqueous MeOH, and extracted with 2 x 100 mL of n-hexane. The dry residue (21.5 g) was re-dissolved in 75 mL of H 2 O, and precipitated by 120 mL of MeOH. The precipitate was washed by 2 x 30 mL of H 2 O: MeOH (1:2) to obtain 18 g of pre-purified extract. This was then subjected to reversephase CC on an octadecyl-silica column (Merck, Darmstadt, Germany; 325 x 28 mm), eluting with 20, 25, 30, 35, and 40, 50 and 60% aqueous MeOH (5 x 100 mL each). Fractions 19-24, containing 20-hydroxyecdysone among other compounds representing similar TLC-UV properties, were pooled and subjected to rotational planar chromatography. A stepwise gradient of EtOAc: EtOH: H 2 O (4:0.25:0.1, 4:0.5:0.25, and 4:1:0.5; 5 fractions each) was used. Compound 1 was obtained from fractions 1-2 by NP-HPLC (Zorbax-sil 9.4 x 250 mm column, isocratic elution with chexane: iPrOH: H 2 O (100:40:3)). RP-HPLC purification of fractions 3-6 (Zorbax ODS 9.4 x 250mm, isocratic elution with MeOH: H 2 O: CH 2 Cl 2 (50:50:1.5)) yielded compounds 2 (1.29 mg) and 3 (1.64 mg).
Bacterial fermentation of compounds 2 and 3:
1.29 mg of compound 1 and 1.64 mg of compound 2 were dissolved in 1.00 mL of methanol, and 750 μL of each were taken out and evaporated for fermentation. Both aliquots were re-dissolved in 30 mL of 37°C physiologic saline solution, and one Probiotik ® capsule (Naturpharma, Budapest, Hungary) was added to each. This supplement is claimed to contain 5 billion bacteria (a mixture of Lactobacillus acidophilus, L. rhamnosus, L. lactis, Bifidobacterium breve, B. bifidum and B. longum) per capsule. The solutions were gently mixed at 37°C for 72 h, and extracted with 5 x 15mL of CH 2 Cl 2 . The organic phases were washed with 3 x 20 mL of water, dried over anhydrous Na 2 SO 4 , re-dissolved in 750 μL of MeOH and investigated by GC-MS as such. The yield of aglycons was estimated by TLC-densitometry at 254 nm with the CP Atlas software (Lázár I & Lázár I jr., University of Debrecen, Debrecen, Hungary), a user-friendly and robust analytical tool [16] freely available at http://lazarsoftware.com. 
